Exploring the anticancer properties of a new nicotinamide analogue: Investigations into in silico analysis, antiproliferative effects, selectivity, VEGFR-2 inhibition, apoptosis induction, and migration suppression.

MLA

Eissa, Ibrahim H., et al. “Exploring the Anticancer Properties of a New Nicotinamide Analogue: Investigations into in Silico Analysis, Antiproliferative Effects, Selectivity, VEGFR-2 Inhibition, Apoptosis Induction, and Migration Suppression.” Pathology, Research and Practice, vol. 252, Dec. 2023, p. 154924. EBSCOhost, https://doi.org/10.1016/j.prp.2023.154924.

APA

Eissa, I. H., Yousef, R. G., Sami, M., Elkaeed, E. B., Alsfouk, B. A., Ibrahim, I. M., Husein, D. Z., Elkady, H., & Metwaly, A. M. (2023). Exploring the anticancer properties of a new nicotinamide analogue: Investigations into in silico analysis, antiproliferative effects, selectivity, VEGFR-2 inhibition, apoptosis induction, and migration suppression. Pathology, Research and Practice, 252, 154924. https://doi.org/10.1016/j.prp.2023.154924

Chicago

Eissa, Ibrahim H, Reda G Yousef, Muhammad Sami, Eslam B Elkaeed, Bshra A Alsfouk, Ibrahim M Ibrahim, Dalal Z Husein, Hazem Elkady, and Ahmed M Metwaly. 2023. “Exploring the Anticancer Properties of a New Nicotinamide Analogue: Investigations into in Silico Analysis, Antiproliferative Effects, Selectivity, VEGFR-2 Inhibition, Apoptosis Induction, and Migration Suppression.” Pathology, Research and Practice 252 (December): 154924. doi:10.1016/j.prp.2023.154924.